Literature DB >> 29861271

A Proposed Mechanism for Neurodegeneration in Movement Disorders Characterized by Metal Dyshomeostasis and Oxidative Stress.

Benjamin Guy Trist1, Dominic James Hare2, Kay Lorraine Double3.   

Abstract

Shared molecular pathologies between distinct neurodegenerative disorders offer unique opportunities to identify common mechanisms of neuron death, and apply lessons learned from one disease to another. Neurotoxic superoxide dismutase 1 (SOD1) proteinopathy in SOD1-associated familial amyotrophic lateral sclerosis (fALS) is recapitulated in idiopathic Parkinson disease (PD), suggesting that these two phenotypically distinct disorders share an etiological pathway, and tractable therapeutic target(s). Despite 25 years of research, the molecular determinants underlying SOD1 misfolding and toxicity in fALS remain poorly understood. The absence of SOD1 mutations in PD highlights mounting evidence that SOD1 mutations are not the sole cause of SOD1 protein misfolding occasioning oligomerization and toxicity, reinforcing the importance of non-genetic factors, including protein metallation and post-translational modification in determining SOD1 stability and function. We propose that these non-genetic factors underlie the misfolding and dysfunction of SOD1 and other proteins in both PD and fALS, constituting a shared and tractable pathway to neurodegeneration.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Parkinson disease; amyotrophic lateral sclerosis; copper; metal dyshomeostasis; oxidative stress; protein misfolding; superoxide dismutase 1

Mesh:

Substances:

Year:  2018        PMID: 29861271     DOI: 10.1016/j.chembiol.2018.05.004

Source DB:  PubMed          Journal:  Cell Chem Biol        ISSN: 2451-9448            Impact factor:   8.116


  13 in total

1.  Resveratrol, Endocrine Disrupting Chemicals, Neurodegenerative Diseases and Depression: Genes, Transcription Factors, microRNAs, and Sponges Involved.

Authors:  Hai Duc Nguyen
Journal:  Neurochem Res       Date:  2022-10-16       Impact factor: 4.414

Review 2.  Implication of post-translationally modified SOD1 in pathological aging.

Authors:  Kashfia Shafiq; Nitesh Sanghai; Ying Guo; Jiming Kong
Journal:  Geroscience       Date:  2021-02-19       Impact factor: 7.713

Review 3.  Connecting RNA-Modifying Similarities of TDP-43, FUS, and SOD1 with MicroRNA Dysregulation Amidst A Renewed Network Perspective of Amyotrophic Lateral Sclerosis Proteinopathy.

Authors:  Jade Pham; Matt Keon; Samuel Brennan; Nitin Saksena
Journal:  Int J Mol Sci       Date:  2020-05-14       Impact factor: 5.923

4.  Kinetic Modeling of pH-Dependent Oxidation of Dopamine by Iron and Its Relevance to Parkinson's Disease.

Authors:  Yingying Sun; A Ninh Pham; Dominic J Hare; T David Waite
Journal:  Front Neurosci       Date:  2018-11-26       Impact factor: 4.677

Review 5.  Switching on Endogenous Metal Binding Proteins in Parkinson's Disease.

Authors:  Fleur A McLeary; Alexandre N Rcom-H'cheo-Gauthier; Michael Goulding; Rowan A W Radford; Yuho Okita; Peter Faller; Roger S Chung; Dean L Pountney
Journal:  Cells       Date:  2019-02-19       Impact factor: 6.600

Review 6.  Oxidative stress in the aging substantia nigra and the etiology of Parkinson's disease.

Authors:  Benjamin G Trist; Dominic J Hare; Kay L Double
Journal:  Aging Cell       Date:  2019-08-20       Impact factor: 9.304

7.  Interdependence of metals and its binding proteins in Parkinson's disease for diagnosis.

Authors:  Athira Anirudhan; Paramasivam Prabu; Jaya Sanyal; Tapas Kumar Banerjee; Gautam Guha; Ram Murugesan; Shiek S S J Ahmed
Journal:  NPJ Parkinsons Dis       Date:  2021-01-04

8.  Variation in the concentration and regional distribution of magnetic nanoparticles in human brains, with and without Alzheimer's disease, from the UK.

Authors:  Jessica Hammond; Barbara A Maher; Imad A M Ahmed; David Allsop
Journal:  Sci Rep       Date:  2021-04-30       Impact factor: 4.379

9.  Novel chemical inhibitor against SOD1 misfolding and aggregation protects neuron-loss and ameliorates disease symptoms in ALS mouse model.

Authors:  Tae-Gyun Woo; Min-Ho Yoon; So-Mi Kang; Soyoung Park; Jung-Hyun Cho; Young Jun Hwang; Jinsook Ahn; Hyewon Jang; Yun-Jeong Shin; Eui-Man Jung; Nam-Chul Ha; Bae-Hoon Kim; Yonghoon Kwon; Bum-Joon Park
Journal:  Commun Biol       Date:  2021-12-15

Review 10.  Empirical evidence for biometal dysregulation in Parkinson's disease from a systematic review and Bradford Hill analysis.

Authors:  Amr H Abdeen; Benjamin G Trist; Kay L Double
Journal:  NPJ Parkinsons Dis       Date:  2022-06-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.